ABG Analytics logo
Get updates

Biogen Inc (NASDAQ: BIIB)

DRUGS - Biotechnology
Sector: Health Care
Stock price data as of 05/17/2019
Closing price: 229.28
Support price level: N/A
Resistance price level: $244.38
Relative strength index (14-day RSI) 49.8
Beta 1.33
  • BIIB is one of this week's most volatile stocks in the S&P-100 with an estimated annualized standard deviation of 36.2%.

  • Volatility is forecast to fall over the next month.

  • BIIB is below its 200-day moving average - additional caution warranted in long positions.

  • Price broke below prior support level - a short-term bearish signal.

Low High Price as % of Range
$216.71 $383.83 9.9%
200 day 50 day 20 day 10 day
$308.18 $246.69 $229.50 $229.63
(Annualized standard deviation)
Historical
(5 year)
Last month Current estimate Next month forecast
37.4% 38.1% 36.2% 37.2%
There is an estimated 5% probability that the stock price of Biogen Inc will fall by more than:
  • 9.8% in the next week.

  • 21.0% in the next month.

  • 79.4% in the next year.